<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00714090</url>
  </required_header>
  <id_info>
    <org_study_id>SAD-001</org_study_id>
    <nct_id>NCT00714090</nct_id>
  </id_info>
  <brief_title>Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression</brief_title>
  <official_title>Repetitive Transcranial Magnetic Stimulation Efficacy for Major Resistant Depression Compared or Associated With Venlafaxine : a Multicentric Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Club rTMS et Psychiatrie</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wyeth is now a wholly owned subsidiary of Pfizer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Club rTMS et Psychiatrie</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the efficacy of add-on therapy with repetitive
      Transcranial Magnetic Stimulation (rTMS) and venlafaxine in the treatment of major depressive
      disorders compared to venlafaxine only (the optimal medication) and to rTMS only.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      rTMS parameters : Intensity of 120% of individually determined motor threshold; frequency : 1
      Hz; 360 impulsions; on period : 1 min; off period : 30 s.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2008</start_date>
  <completion_date type="Actual">July 2013</completion_date>
  <primary_completion_date type="Actual">July 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The primary outcome measure is remission. It will be evaluated using the Hamilton Depression Rating Scale (HDRS-17 &lt; 8)and Montgomery Asberg Depression Rating Scale (MADRS)</measure>
    <time_frame>2 to 6 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Onset of action for remission and response (HDRS-17 diminution &gt; 50%)</measure>
    <time_frame>2 to 6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety will be assessed using the Covi Anxiety Scale.</measure>
    <time_frame>2 to 6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Side effects will be assessed using the UKU Scale.</measure>
    <time_frame>2 to 6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of depression using 2 other scales : the Montgomery Asberg Depression Rating Scale (MADRS) and the Beck Depression Inventory scale (BDI-13)</measure>
    <time_frame>2 to 6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Onset of action using the Clinical Global Impressions scale (CGI)</measure>
    <time_frame>2 to 6 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">170</enrollment>
  <condition>Unipolar Depression</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Double active comparator : venlafaxine (150 mg/day) and rTMS (5 times/week)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>active rTMS (5 times/week) and sham venlafaxine (150 mg/day)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>C</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>sham rTMS (5 times/week) and active venlafaxine (150 mg/day)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>active venlafaxine and active rTMS-repetitive transcranial magnetic stimulator, Inomed and Alpine Biomed</intervention_name>
    <description>active venlafaxine LP 75 mg : 1 capsule per day for 3 days, then 2 per day for 2 to 4 weeks, if necessary 3 per day the next 2 weeks.
active rTMS : 5 sessions per week for 2 to 6 weeks</description>
    <arm_group_label>A</arm_group_label>
    <other_name>venlafaxine, Wyeth</other_name>
    <other_name>repetitive transcranial magnetic stimulator, Inomed</other_name>
    <other_name>repetitive transcranial magnetic stimulator, Alpine Biomed</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>active rTMS -repetitive transcranial magnetic stimulator, Inomed and Alpine Biomed and sham venlafaxine</intervention_name>
    <description>active rTMS : 5 sessions per week for 2 to 6 weeks sham venlafaxine LP 75 mg : 1 capsule per day for 3 days, then 2 per day for 2 to 4 weeks, if necessary 3 per day the next 2 weeks.</description>
    <arm_group_label>B</arm_group_label>
    <other_name>repetitive transcranial magnetic stimulator, Inomed</other_name>
    <other_name>repetitive transcranial magnetic stimulator, Alpine Biomed</other_name>
    <other_name>venlafaxine, Wyeth</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>sham rTMS- repetitive transcranial magnetic stimulator, Inomed and Alpine Biomed and active venlafaxine</intervention_name>
    <description>sham rTMS : 5 sessions per week for 2 to 6 weeks active venlafaxine LP 75 mg : 1 capsule per day for 3 days, then 2 per day for 2 to 4 weeks, if necessary 3 per day the next 2 weeks.</description>
    <arm_group_label>C</arm_group_label>
    <other_name>repetitive transcranial magnetic stimulator, Inomed</other_name>
    <other_name>repetitive transcranial magnetic stimulator, Alpine Biomed</other_name>
    <other_name>venlafaxine, Wyeth</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults

          -  Clinical diagnosis of major depressive disorder (DSM-IV)

          -  HDRS-17 items &gt; 20

          -  Failure of one antidepressant treatment (efficacious doses for 6 weeks at least)

        Exclusion Criteria:

          -  I or II bipolar disorder

          -  Psychotic features

          -  Failure of one previous venlafaxine treatment

          -  Addiction comorbidity or schizophrenia comorbidity

          -  Involuntary hospitalization

          -  Seizures history

          -  Pregnancy or breastfeeding

          -  Somatic comorbidity able to impact on cognitive functions
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emmanuel POULET, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>EA 4615 - SIPAD, Unité de Recherche UCB Lyon 1/CH Le Vinatier - Department of Psychiatry - Service du Pr d'AMATO</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>C.H.U. Saint-Jacques - Service de Psychiatrie de l'Adulte</name>
      <address>
        <city>Besançon</city>
        <zip>25000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>C.H. Le Vinatier - EA 4166, UCB Lyon 1 - Department of Psychiatry - Service du Pr d'AMATO</name>
      <address>
        <city>Bron</city>
        <zip>69500</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>C.H.U. Gabriel Montpied - Service de Psychiatrie et Psychologie Médicale - CMP A</name>
      <address>
        <city>Clermont Ferrand</city>
        <zip>63000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Louis Mourier</name>
      <address>
        <city>Colombes</city>
        <zip>92700</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>C.H.U. Dijon, Hôpital Général - Service de Psychiatrie et d'Addictologie</name>
      <address>
        <city>Dijon</city>
        <zip>21000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>C.H.U. de Grenoble, Hôpital sud - Département de Psychiatrie</name>
      <address>
        <city>Grenoble</city>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Fontan - C.H.R.U. Lille</name>
      <address>
        <city>Lille</city>
        <zip>59000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASM Limoux</name>
      <address>
        <city>Lézignan-Corbières</city>
        <zip>11200</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>C.H. Sainte Marguerite</name>
      <address>
        <city>Marseille</city>
        <zip>13000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU - Hôpital La Colombière</name>
      <address>
        <city>Montpellier</city>
        <zip>34000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Pasteur - CHU Nice</name>
      <address>
        <city>Nice</city>
        <zip>06000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Sainte Anne - Service Hospitalo-Universitaire de Santé Mentale et de Thérapeutique</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>C.H.U. de POITIERS</name>
      <address>
        <city>Poitiers</city>
        <zip>86000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>C.H.U. - C.H. Guillaume Régnier</name>
      <address>
        <city>Rennes</city>
        <zip>35000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>C.H.U. Charles Nicolle - Service Hospitalo-Universitaire de Psychiatrie</name>
      <address>
        <city>Rouen</city>
        <zip>76000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>EPS de Ville Evrard - Unité de Saint-Denis</name>
      <address>
        <city>Saint-Denis</city>
        <zip>93200</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU St Etienne - Hôpital Nord</name>
      <address>
        <city>St Etienne cedex</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Princesse Grace</name>
      <address>
        <city>Monaco</city>
        <zip>98000</zip>
        <country>Monaco</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
    <country>Monaco</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 10, 2008</study_first_submitted>
  <study_first_submitted_qc>July 11, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 14, 2008</study_first_posted>
  <last_update_submitted>July 18, 2013</last_update_submitted>
  <last_update_submitted_qc>July 18, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 19, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Club rTMS et Psychiatrie</investigator_affiliation>
    <investigator_full_name>Dr Emmanuel POULET</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <keyword>repetitive Transcranial Magnetic Stimulation (rTMS)</keyword>
  <keyword>Major depressive disorders</keyword>
  <keyword>Depression</keyword>
  <keyword>Venlafaxine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Venlafaxine Hydrochloride</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

